Zhongxun Yu

704 citations
32 papers · 448 indexed · h-index 11
Topics
Inflammasome and immune disorders (7 papers)Systemic Lupus Erythematosus Research (5 papers)DNA Repair Mechanisms (3 papers)

In The Last Decade

Zhongxun Yu

25 papers receiving 442 citations

Peers

Zhongxun Yu
Comparison fields: 5 of 72
  • Molecular Biology 193
  • Oncology 123
  • Electrical and Electronic Engineering 85
  • Immunology 80
  • Epidemiology 76
Replace Qianwen Hu with:
Qianwen Hu China
Yaqing Yang China
Chengcheng Liao China
Wenyu Zhang China
Weijie Dong China
Xia Kang China
Jacqueline Lypowy United States
Shambhabi Chatterjee Germany
M. Ariel Kauss United States
Dae Kwang Jung United States
Zhongxun Yu relative to Qianwen Hu China Qianwen Hu's profile →
Citations per field
00.5×10×20×28.3×
Qianwen Hu · 1×
Citations per year

Countries citing papers authored by Zhongxun Yu

Since Specialization
Citations

This map shows the geographic impact of Zhongxun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongxun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongxun Yu more than expected).

Fields of papers citing papers by Zhongxun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongxun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongxun Yu. The network helps show where Zhongxun Yu may publish in the future.

Co-authorship network of co-authors of Zhongxun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongxun Yu. A scholar is included among the top collaborators of Zhongxun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongxun Yu. Zhongxun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 11
5 66
6 0
7 1
8 1
9 1
10 4
11 1
12 10
13 5
14 11
15 4
16 25
17 21
18 12
19 176
20
Effects of angiotensin II and losartan on the growth and proliferation of hepatic stellate cells.
4

About Zhongxun Yu

Zhongxun Yu is a scholar working on Rheumatology, Immunology and Hepatology, having authored 32 papers that have together received 448 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Systemic Lupus Erythematosus Research (5 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Physiology (40 citations), Geriatrics and Gerontology (29 citations) and Oncology (123 citations). Zhongxun Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hongmei Song, Robert W. Sobol, Guy G. Poirier, Elise Fouquerel, Jean‐Philippe Gagné, Michelle Barbi de Moura, Eva M. Goellner, Marie E. Migaud, Philip Redpath and Guillermo Romero. Their work appears in journals such as Nucleic Acids Research, Advanced Materials and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026